Drugs / r-hCG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01112358 Background | Dec 2005 → Jan 2007 | ovarian hyperstimulation syndrome | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | r-hCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01112358 ↗ |
| Modality | Protein / enzyme biologic | “recombinant Human Chorionic Gonadotropin” NCT01112358 ↗ |